Indotan Chemicals Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 17-06-2024
- Paid Up Capital ₹ 5.35 Cr
as on 17-06-2024
- Company Age 36 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.14 Cr
as on 17-06-2024
- Satisfied Charges ₹ 34.49 Cr
as on 17-06-2024
- Revenue 35.00%
(FY 2023)
- Profit 26.41%
(FY 2023)
- Ebitda 26.39%
(FY 2023)
- Net Worth 190.38%
(FY 2023)
- Total Assets 37.21%
(FY 2023)
About Indotan Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.35 Cr.
The company currently has active open charges totaling ₹20.14 Cr. The company has closed loans amounting to ₹34.49 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ankit Juneja, Ruchi Juneja, and Ramesh Juneja serve as directors at the Company.
- CIN/LLPIN
U51109WB1988PLC044751
- Company No.
044751
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Jul 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Indotan Chemicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankit Juneja  | Director | 10-Apr-2007 | Current |
| Ruchi Juneja | Director | 18-Apr-2012 | Current |
| Ramesh Juneja | Director | 10-May-2007 | Current |
Financial Performance of Indotan Chemicals.
Indotan Chemicals Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 35% increase. The company also saw a substantial improvement in profitability, with a 26.41% increase in profit. The company's net worth Soared by an impressive increase of 190.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indotan Chemicals?
In 2023, Indotan Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Bengal Juneja Leather Complex LimitedActive 17 years 9 months
Ankit Juneja and Ramesh Juneja are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 13 Feb 2024 | ₹4.28 Cr | Open |
Others Creation Date: 14 Sep 2022 | ₹14.94 Cr | Open |
Others Creation Date: 14 Sep 2022 | ₹6.70 M | Open |
How Many Employees Work at Indotan Chemicals?
Indotan Chemicals has a workforce of 124 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indotan Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indotan Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
